EX Healthcare is developing a new healthcare solution from the technology that regulates the secretion naturally released by the skin. We have a technology that boosts the role of the skin so that certain secretions (Trasn-some) that are secreted from the skin and move to other organs contain abundant miRNAs that control the human body's signals and can move to the target organ. EX Healthcare successfully launched the "dermaFIT" brand that targets muscles in the U.S. market by applying the technology (exported $620,000 in 2024), and now aims to enter new markets in Korea and Europe based on this. Depending on the target organ and miRNA, this technology is highly scalable as it has various effects from head to toe to target. We are currently developing a solution for applying healthcare in all areas targeting non-muscle organs. We are also conducting basic research to apply the technology to health functional foods, biopharmaceuticals, and disease prevention management applications, and developing solutions that can implement a healthier life for even one customer.